U.S., May 7 -- ClinicalTrials.gov registry received information related to the study (NCT06959550) titled 'Phase II Study of Anti-PD-1/VEGF Bispecific Antibody Ivonescimab in Patients With Previously Treated Metastatic Colorectal Cancer' on April 28.
Brief Summary: The goal of this clinical research study is to learn if ivonescimab can help to control previously treated, metastatic colorectal cancer.
Study Start Date: Oct. 01, 2025
Study Type: INTERVENTIONAL
Condition:
Metastatic Colorectal Cancer
Intervention:
DRUG: Ivonescimab
Given by IV
Recruitment Status: NOT_YET_RECRUITING
Sponsor: M.D. Anderson Cancer Center
Disclaimer: Curated by HT Syndication....